Business Update

Hi-Tech enters into agreement with Victory Pharma to market and distribute Naprelan

Published in Lab Law Weekly, February 2nd, 2007

Hi-Tech Pharmacal Co., Inc., (HITK) announced that it has entered into an agreement with Victory Pharma, Inc., to market Naprelan in the United States.

Naprelan extended-release tablets are a nonsteroidal anti-inflammatory, licensed by Hi-Tech from Elan Pharmaceuticals, Inc. Victory, based in San Diego, California, will promote Naprelan directly to physicians through its sales and marketing force. Hi-Tech concurrently terminated the marketing and distribution agreement with Blansett Pharmacal, its previous marketing partner.

Additionally, Hi-Tech has signed an agreement to sell Naprelan to Victory Pharma subject to the satisfaction of certain...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2007-02-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry